Hlavní stranaMezinárodní biotech událostiImmuno-Oncology

Immuno-Oncology

 

Copthorne Tara Hotel, London, UK (September, 25 - 27, 2018)

.

.

Main Conference: 26 – 27 September 2018

Pre-Conference Workshops: 25 September 2018

 

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies.

SMi's Immuno-Oncology Conference will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.

 

At the SMi's Immuno-Oncology Conference participants will get:

 

Agenda -  Over 15 engaging presentations, case studies, keynote addresses, including:

  • Targeting immune checkpoints with Humabody VH therapeutics
  • Recent advances in providing durable disease control with Keytruda as an anti-cancer therapy
  • Tumour mutation burden and the potential of its use as an indication of treatment choice
  • Unwanted immunogenicity and functionality testing of immuno-oncology drugs
  • New techniques, such as the emerging applications of liquid biopsies, in Immuno-Oncology

 

Speakers – Over 15 leading experts in Immuno-Oncology field, including:

 

  • James Legg, Vice President R&D, Crescendo Biologics
  • Andrew Exley, Medical Assessor, MHRA
  • Harry Smith, Medical Scientist, Gilead Sciences
  • Grace Macaulay, Global Safety Physician Patient Safety Oncology, MedImmune
  • David Giljohan, CEO, Exicure
  • Kandeepan Ganeshalingam, Executive Director, Oncology Therapeutic Area Head, European Clinical Development, MSD
  • Rochana Wickramasinghe, Director of Oncology Evaluation, AstraZeneca

 

Workshops - Carefully selected topics for further on-sight training. 2 pre-conference workshops (25 September) to provide in-depth knowledge on specific topics:

 

  • Strategic Competitive Intelligence in the Immuno-Oncology space - hosted by LucidQuest Ventures
  • Could the Microbiome boost Cancer Immuno-Therapy - hosted by ImmuneBiotech and Lund University

 

Networking - it is at the forefront of SMi events. 5+ hours of pure networking guaranteed. Follow event updates to be in the know about who will be joining the conversation.

 

To View detailed information about event programme, speaker line-up and workshop agenda visit http://www.immuno-oncology-conference.com/get2bioWL  

  

Twitter - @SMIpharm & #immunooncologysmi

LinkedIn - SMi Pharma

Více: http://www.immuno-oncology-conference.com/get2bioWL

OPPI, MPO, EU
Czech Bio

Doporučujeme

Biosimilars

CEBIO a I. etapa JVTP

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

Provozovatel

Jihočeská agentura pro podporu inovačního podnikání o.p.s.

Články na přání


[načítám anketu]

LinkedIn